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Summary: We have generated a mouse line with a
mutant allele of the mouse Bruce/Birc6 gene induced by
gene trap mutagenesis. Based on its structural features,
Bruce is a member of the family of apoptosis inhibitor
proteins (IAPs). This mutation leads to a truncated tran-
script and protein and results in a complete loss of the
wildtype Bruce protein. Bruce mutant mice die from a
progressive loss of their placental spongiotrophoblast
layer between day 11.5 and 14.5 of embryonic develop-
ment. The cause of the Bruce homozygous mutant phe-
notype is a lack of proliferation of spongiotrophoblast
cells in the developing placenta. In contrast to in vitro
data, which indicate a function for Bruce in apoptosis
inhibition, the in vivo results presented here suggest
instead a role for Bruce in cell division. genesis 42:91–
103, 2005. VC 2005 Wiley-Liss, Inc.
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During evolution the eutherian organisms invented the
placenta as a direct connection between an embryo and
its mother, which allows development independent
from most environmental influences. In contrast to the
closely related sauropsida, the mammalian egg suffers
from a secondary lack of vitelline fluid and the embryo
relies mostly on a maternal supply of oxygen and
nutrients. To establish the close contact between the
embryo and its mother, extraembryonic trophoblast
cells are actively invading the uterine wall during
implantation. In contrast to the human, the mouse pla-
centa consists of three cell layers. Two of them, the giant
cell layer and the spongiotrophoblast, are of trophecto-
dermal origin, whereas the labyrinthine layer is consti-
tuted of extraembryonic mesoderm and trophoblast
cells (for a review, see Rossant and Cross, 2001).
Several signals from the embryo, the mother, and the
environment control the complex processes of placental
development. Oxygen content is one of the key trigger-
ing signals, capable of inducing immediate responses by
trophectodermal cells in vivo and in vitro. For example,
trophoblast cells are sensitive to hypoxia and produce
HIF1/ARNT and VEGF in response, which subsequently
stimulates the proliferation of endothelial cells by tran-
scriptional activation of a number of genes (Adelman
et al., 2000; Damert et al., 1997). In addition, low O2 lev-
els promote differentiation into spongiotrophoblast and
thus regulate the fate of placental cells (Adelman et al.,
2000; Schaffer et al., 2003; Levy et al., 2000). Growth
factor signals from the embryo are also required for dif-
ferentiation of trophoblast cells. Since the placenta
needs to constantly keep up with the growing embryo,
it undergoes permanent tissue remodeling, which is
facilitated by the release of matrix metalloproteinases
(Teesalu et al., 1999). As a consequence, cells of the pla-
centa are not only undergoing proliferation, but also
extensive apoptosis (for a review, see Levy et al., 2000).
Apoptosis in the placenta can be triggered by extrinsic
signals, namely FasL/Fas or the TNFalpha/TNFR systems
(Uckan et al., 1997; Crocker et al., 2001; Straszewski-
Chavez et al., 2004). Molecularly best understood are
intrinsic apoptotic cascades which are initiated by mito-
chondrial release of cytochrome c and diablo/smac in
response to cellular triggers such as DNA damage or
hypoxia. Both apoptotic pathways involve the activation
of initiator and effector caspases. Once activated, the
proteolytic caspase pathway ultimately leads to the
The Supplementary Material in this article can be accessed at http://
www.interscience.wiley.com/jpages/1526-954X/suppmat.
* Correspondence to: W. Wurst, GSF National Research Center for Envi-
ronment and Health, Institute of Developmental Genetics, Ingolstaedter
Landstrasse 1, 85764 Neuherberg, Germany.
E-mail: wurst@gsf.de or tfloss@gsf.de
Contract grant sponsors: Bundesministerium fuer Bildung und Forschung
(BMBF) (to P.R. and W.W.) in the framework of the Deutsches Human
Genom Projekt (DHGP), and the Nationales Genomforschungs Netz
(NGFN).
Abbreviations: VEGF, vascular endothelial growth factor; FGF4,
fibroblast growth factor 4; IAP, inhibitor of apoptosis protein; BIR,
baculovirus IAP repeat; UBC, ubiquitin conjugating; BRUCE, baculovi-
rus repeat UBC containing enzyme.
Published online in Wiley InterScience (www.interscience.wiley.com).
DOI: 10.1002/gene.20128
' 2005 Wiley-Liss, Inc. genesis 42:91–103 (2005)
cleavage of a wide spectrum of cellular targets and
causes cell death (Thornberry and Lazebnik, 1998; Shi,
2001). For the human it has recently been shown that
caspase 8-mediated cell fusion is a prerequisite for the
maintenance of the syncytiotrophoblast, which is
homologous to the murine labyrinth (Black et al., 2004).
The delicate balance between proliferation, differentia-
tion, and apoptosis needs to be tightly regulated in the
placenta and any imbalance can lead to malformation or
death of the developing embryo. Molecules with a
potentially negative impact on apoptosis in vivo are the
inhibitor of apoptosis proteins (IAPs), most of which
have been shown to bind and inhibit caspases in vitro
(Wilson et al., 2002; Shiozaki et al., 2003). In addition,
several IAPs are able to bind to the mammalian RHG
motif-containing proteins Smac/diablo and HtrA2/Omi,
which are potent apoptosis inducers (Du et al., 2000;
Suzuki et al., 2001).
The huge Bruce protein of 528 kDa contains one N-
terminal baculovirus inhibitor of apoptosis repeat (Bir)
domain as well as a C-terminal ubiquitin-conjugating
(UBC) domain (Hauser et al., 1998). More recently, IAP
family members have been divided into two subgroups,
based on their Bir repeat type. One group contains
between one and three N-terminal Bir repeats and either
a C-terminal ring finger or an additional caspase recruit-
ment domain (CARD); the other contains a ‘‘survivin-
like’’ Bir domain and comprises Survivin and Bruce
(Verhagen et al., 2001). Proteins with the slightly larger
survivin-like Bir repeat sequence can be found in yeast
(Spbir1P), nematode (BIR-1, BIR-2), and fly (d-Bruce,
Deterin) and are therefore older in evolutionary terms
compared to other IAPs. In Caenorhabditis elegans and
the yeasts Schizosaccharomyces pombe and Saccharo-
myces cerevisiae the Bir proteins do not inhibit apopto-
sis but instead have been shown to have a role in cell
division (Uren et al., 1999; Silke and Vaux, 2001; Fraser
et al., 1999). This observation is further supported by
the fact that no caspase or Bcl-2 gene has been found in
single-celled organisms, although examples of cell sui-
cide have been described (Vaux and Korsmeyer, 1999).
Bir-1 mutant zygotes of C. elegans do not finish cytokine-
sis, bir1 deficient S. pombe exhibit defects in mitotic
spindle elongation, and the Bir1p protein of S. cerevi-
siae has been shown to be associated with kinetochore
proteins. The exact molecular function of nematode and
yeast IAPs is not known. It has been proposed for Bir-1
that it may serve as an adaptor molecule in larger com-
plexes (Yoon and Carbon, 1999; Rajagopalan and Balasu-
bramaian, 1999; Speliotes et al., 2000). Mutations in the
Drosophila homolog of Bruce (d-Bruce) leads to
enhanced apoptosis during spermatogenesis induced by
reaper and grim and causes male sterility. However, in
Drosophila the apical cell death caspase, Dronc, is not
blocked by d-Bruce (Vernooy et al., 2002; Arama et al.,
2003). Mammalian Bruce is probably also not directly
interacting with caspases but antisense oligonucleotides
directed against Bruce accelerate the sensitivity of SNB-
78 glioma cells to apoptosis induced by DNA-damaging
agents (Chen et al., 1999). More recently, it has been
demonstrated, that a knockdown of Bruce by RNAi in
HeLa and MCF-7 cells was sufficient to induce apoptosis.
Moreover, it was shown that the ubiquitin ligase Nrdp1
is capable of triggering apoptosis through ubiquitination
of Bruce (Qiu et al., 2004). In contrast to most other
usually ring finger containing IAP family members,
which are therefore ubiquitin ligases (E3; Joazeiro and
Weissman, 2000), and in contrast to the closely related
Survivin, which does not contain any other functional
domain, the second domain of Bruce provides E2 ubiqui-
tin-conjugating enzyme activity (E2). The functionality
of the UBC domain has been demonstrated in vitro
(Hauser et al., 1998). Based on its unique protein struc-
ture, it has been suggested that Bruce may ubiquitinate
caspases directly and could serve as a cellular link
between the 26S proteasome and the apoptosis cascade.
However, depending on the number of ubiquitin resi-
dues, which are transferred to a cellular target, other cel-
lular processes such as endocytosis, DNA repair, and
transcriptional control may be triggered and only multi-
ubiquitination of at least four or more ubiquitin residues
leads to degradation by the proteasome (Jesenberger
and Jentsch, 2002). Bruce is expressed ubiquitously
both in embryonic and extraembryonic tissue as well as
in embryonic stem cells.
In a large-scale gene trap screen, we produced an
allelic series of gene trap vector integrations in the
Birc6/Bruce gene on mouse chromosome 17, the homo-
log of the human IAP protein APOLLON. For reasons yet
unknown, Bruce is a hot spot for gene trap mutagenesis,
with currently 30 integrations generated by the Interna-
tional Gene Trap Consortium (IGTC; in ensembl.org/
mus musculus: ENSMUSG00000024073; check ‘‘gene
trap’’ in DAS sources). In a recent bioinformatic analysis
of gene trap data, we excluded at least its impressive
gene size of 175 kb and 73 exons as the most likely rea-
son for being a gene trap hot spot (Hansen et al., 2003).
From an ES cell clone carrying an integration in intron
45 (also referred to as ‘‘W036C08’’ according to the
GGTC database clone identifier), we established a
mutant mouse line (Birc6Gt(pT1Betageo)45Flo) by blastocyst
injection. The mutation in the murine Bruce leads to
embryonic lethality at variable stages of embryonic
development. Since the mutant embryos did not always
show obvious alterations, we performed a morphologi-
cal analysis of extraembryonic structures in the mutants.
We can show that homozygous embryos carrying a gene
trap vector integration in the Bruce gene die from a rela-
tive regression of their spongiotrophoblast layer
between embryonic day (E)11.5 and E14.5.
RESULTS
The integration of gene trap vectors into the genome is a
random event and with splicing acceptor containing
gene trap vectors usually integrations in introns are
selected. According to the initial 50 RACE sequence of
the clone W036C08, the pT1betageo gene trap vector
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had integrated in intron 45 of the Bruce gene. The iden-
tity of the clone and the exact intronic integration site
was confirmed by repetition of 50 RACE-PCR by South-
ern blot analysis and by genomic PCR (Fig. 1). The inte-
gration site at base 112.326 of the Bruce gene (ensem-
bl.org; MUS MUSCULUS | CHROMOSOME: NCBIM32:
17:75105982:75280750:1) was determined by PCR
amplification of genomic DNA obtained from the respec-
tive ES cell clone with primer pair ‘‘1489’’ and ‘‘lac2’’ and
sequencing of the cloned PCR product.
We determined that 1486 bases of the initial 1688 bases
of the intron of the mouse Engrailed-2 splicing acceptor
were lost during the integration event (Fig. 1A). Southern
analysis was done using an internal neomycin probe after
digestion with either HindIII or EcoRI. After genomic inte-
gration of pT1betageo, no HindIII restriction sites are left
(Wiles et al., 2000). EcoRI has one restriction site in
pT1betageo (Fig. 1B). Since we obtained a single 20 kb
band after HindIII digestion but a 7 kb and a 10 kb band
after EcoRI digestion, we concluded that in the ES clone
W036C08 two pT1betageo plasmid vectors had inte-
grated in tandem into the Bruce locus (Fig. 1B). As a
hybridization control, we used an unrelated Engrailed-1
genomic probe (ESN) simultaneously.
We established five chimeric males of the clone
W036C08, two of which transmitted the mutation
through the germline and were further bred to homo-
zygosity (Birc6Gt(pT1Betageo)45Flo). A genotyping strategy
using a triplex PCR assay was developed based on the
integration sequences (Fig. 1B).
We determined the expression of Bruce in wildtype
embryos at E11.5 and E18.5 by in situ hybridization
using a Bruce antisense probe. Bruce was determined to
be widely expressed with strongest expression in brain
and neural tube, dorsal root ganglia, trigeminal ganglia,
lung, liver, urogenital fold, and heart (Fig. 2A). The wild-
type expression pattern was reflected in the mutant by
the lacZ reporter in a gene dosage-dependent manner, as
expected. The strongest lacZ staining was found
in brain, neural tube, heart, and dorsal root ganglia
(Fig. 2B).
In order to determine whether the integration of the
gene trap vector had resulted in a truncated protein as
predicted, we performed a Western analysis on protein
from F2 littermates at E10.5 (Fig. 1C). By using an N-ter-
minal antibody for the Bruce protein, which recognizes
amino acids N-terminal of the Bir repeat of the wildtype
protein (a gift of K. Lotz), we determined for W036C08
that heterozygous embryos express two different pro-
teins in a 1:1 ratio, the 528 kDa wildtype Bruce protein
and a 470 kDa fusion protein of Bruce and betageo, the
result of the utilization of the En-2 splicing acceptor of
the gene trap vector pT1betageo, as indicated also by a
lacZ antibody, which detects only the mutant protein.
FIG. 1. A: The integration of pT1betageo in intron 45 of the Bruce gene (W036C08). This allele was designated (Birc6Gt(pT1Betageo)45Flo). Note
that 202 bp of the engrailed 2 intron were lost during the integration. Red: Bruce genomic sequence, blue: en-2 intron sequence, black:
sequence of unknown origin. B1: The integration of pT1betageo in intron 45 (W036C08) occurred in tandem as shown in a Southern blot (B2)
using an internal neomycin probe after EcoRI and HindIII digest of genomic DNA from wildtype (wt) and heterozygous animals. B3: Genotyp-
ing assay using a multiplex PCR with primers 1–3 (B1). C1: Schematic overview of the wildtype Bruce protein with the N-terminal Bir domain
and the C-terminal UBC domain and the predicted fusion proteins after integrations in intron 45 (W036C08). C2:Western analysis using pro-
tein of Bruce mutant embryos at E10.5: W036C08: Upper lane: the antibody against the N-terminus of Bruce recognizes both the wt and the
fusion protein. No wt protein was found in homozygous embryos. Second lane: The antibody against the Bruce C-terminus recognizes only
the larger wt protein. Third lane: The antibody against betagal recognizes only the smaller fusion protein. Lower lane: An antibody against
beta actin was used as a loading control. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com]
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FIG. 2. Bruce expression at E11.5 and E18.5 by in situ hybridization and lacZ staining at E11.5. A: left: E11.5, right: E18.5: The Bruce wild-
type (wt) in situ hybridization reveals widespread expression mainly in brain, neural tube, dorsal root ganglia, trigeminal ganglion, tongue,
lung, and heart. B: lacZ staining reflects the wt expression pattern in the mutant. LacZ is expressed in a gene dosage-dependent manner:
left heterozygous mutant at E11.5, right side: homozygous littermate. fb: forebrain, mb: midbrain, hb: hindbrain, nt: neural tube, h: heart,
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The wildtype Bruce protein is entirely replaced by the
smaller fusion protein in homozygous mutants. The C-
terminal antibody, which is directed against the UBC
domain of Bruce (K. Lotz, pers. commun.), does not
yield any signal in homozygous mutants, indicating uti-
lization of the En-2 splicing acceptor of the gene trap
vector and truncation of Bruce after exon 46. As a load-
ing control, an antibody against beta actin was used (Fig.
1C). After determining that no wildtype protein is made
from the mutant allele of W036C08, we systematically
investigated the embryonic development of the mutants.
After genotyping a total of 80 F2 offspring of the strain
W036C08, we determined that no homozygous mutants
had survived until weaning. We therefore genotyped F2
embryos at different stages of development (Fig. 3).
Starting at E10.0, a total of seven homozygous W036C08
embryos were found among 35 pups from five litters,
thus at a lower rate than expected. An average below
20% homozygotes could be found throughout embry-
onic development until E14.5. No homozygous mutants
were found among embryos older than E14.5 or new-
borns, indicating embryonic or perinatal lethality of the
mutation. Morphologically, the majority of homozygous
W036C08 mutant embryos appeared normal (Fig. 2B);
however, 10% of those were being resorbed and pres-
ently underwent extensive necrosis starting as early as
E11.5 (Fig. 4).
The LacZ expression pattern of embryos and their cor-
responding placentas revealed that the morphology of
the mutant placentas differed from heterozygous litter-
mates at E11.5 (Fig. 4C). Compared to heterozygous lit-
termates, there was no spongiotrophoblast layer visible;
FIG. 4. Placental phenotype of W036C08. A: Sections through heterozygous placenta from C stained with hematoxylin at E11.5. B: Pla-
centa of a homozygous littermate from C. Note that the spongiotrophoblast of a severely affected embryo (C left side) is strongly regressed.
B’: Higher magnification from B with trophoblast giant cells and adjacent cell layers. A large number of pycnotic nuclei indicates extensive
necrosis. Both placentas of A and B are shown in C with the respective embryos after lacZ staining: Left side: homozygous embryo
attached to its placenta. Right side: heterozygous placenta with its corresponding embryo above. Note that strongest lacZ expression was
detected in the spongiotrophoblast layer. Note that the embryo is currently being resorbed and that the lacZ staining pattern of the placenta
indicates the absence of the spongiotrophoblast layer. All lacZ staining appears to be located in the labyrinth. Dec: decidua, gia: trophoblast
giant cells, lab: labyrinth, spo: spongiotrophoblast.
FIG. 3. Genotyping of Bruce embryos over time: Embryos from
het/het matings were prepared at different stages of development.
No more than 10–20% mutant embryos were found for W036C08
starting at E10 with a dramatic decrease of mutants in the litters
after E12.5. All homozygous embryos found at E14.5 displayed
severe malformations and no homozygotes were found after this
stage. Dashed line: heterozygote embryos; dotted line: wildtype
embryos; continuous line and dot at P20: homozygous embryos.
n ¼ total number of genotyped embryos.
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instead, all residual lacZ staining appeared to be
restricted to the labyrinthine layer in these mutants.
Embryos connected to these severely malformed placen-
tas presently underwent resorption. After sectioning and
hematoxylin stainings we found that the spongiotropho-
blast layer of the affected embryos was either largely
reduced or missing (compare Fig. 4A,B). At this stage
most of the labyrinthine cells underwent necrosis, as
indicated by large numbers of pycnotic nuclei. In order
to determine whether Bruce is already expressed in
extraembryonic tissue before the layers of the placenta
are established after chorio-allantoic fusion, we took
advantage of the lacZ reporter cassette. Heterozygous
embryos were sacrificed at E7.5 and stained for lacZ
expression. We determined that Bruce is expressed in
the chorion and ectoplacental cone, which is the spon-
giotrophoblast precursor (Fig. 5A). Expression was also
found in trophoblast giant cells and in the late gastrula
stage embryo (Fig. 5B,D). No lacZ expression was found
in the amnion and in the allantois (Fig. 5B).
In order to determine whether early spongiotropho-
blast development occurs normally in nonaffected
embryos, we generated in situ hybridization probes spe-
cific for the labyrinth and the spongiotrophoblast layer.
Both layers have been shown to express different VEGF
receptors: flt-1 is exclusively expressed in the spongio-
trophoblast and flk-1 is restricted to the labyrinth
(Dumont et al., 1995).
Placentas were chosen from embryos between stage
E10.5 and E12.5. All homozygous placentas of morpho-
logically unaffected embryos were isolated, fixed in 4%
>paraformaldehyde (PFA), embedded in paraffin, and
subsequently sectioned. As indicated in Figure 6, the
gross appearance of mutant placentas was normal at
E10.5. The Bruce mRNA is highly abundant in both the
labyrinth and the spongiotrophoblast. In the mutant pla-
centas no Bruce mRNA was detectable by in situ hybrid-
ization (Fig. 6B4,D4). The spongiotrophoblast layer is ini-
tially established in the mutants, as shown by the pres-
ence of flt-1 positive cells. However, with some
variability, there is no further extension of flt-1-positive
tissue after E10.5 (Fig. 6D2,F2) in the fast-growing pla-
centa. The labyrinthine layer, as shown by flk-1-positive
signals, is apparently developing normally between
E10.5 and E12.5. However, the labyrinthine layer
appears to be more loosely packed in the mutant as com-
pared to the wildtype starting at E11.5 (not shown).
From the significant reduction of flt-1-positive cells in
the mutant, we concluded that the primary impact of
this Bruce mutation is on the spongiotrophoblast layer
of the mutant placentas. This finding is further sup-
ported by a strong reduction of mash2 and Hif1 alpha
expression and EGFR protein in mutant spongiotropho-
blast (Fig. 7). In order to determine whether spongiotro-
phoblast cells of morphologically yet unaffected emb-
ryos undergo enhanced apoptosis, we performed Tunel
analyses and determined the presence of cleaved cas-
pase 3 (Fig. 8). Between 0 and 12 cleaved caspase 3-posi-
tive cells were detected in both the wildtype and in the
mutant spongiotrophoblast and labyrinth. (Fig. 8B,D and
Supplementary data). We confirmed that no significant
differences in the number of apoptotic events by Tunel
FIG. 5. LacZ expression of
W036C08 in extraembryonic tis-
sue at E7.5. A: LacZ is found
in the chorion and the ectopla-
cental cone, which is the precur-
sor of the spongiotrophoblast
layer. B: LacZ is not expressed in
the amnion or allantois prior to
chorio-allantoic fusion. C: LacZ
expression in the embryonic ecto-
and endoderm. D: LacZ expres-
sion in trophoblast giant cells.
Cho: chorion, etc., cone: ectopla-
cental cone, emb: embryo, amn:
amnion, all: allantois, gia: tropho-
blast giant cells.
96 HITZ ET AL.
and cleaved caspase 3 staining were evident between
mutants and wildtype (Fig. 8E,F). These results suggest
that apoptosis is not involved in the early growth retar-
dation of the mutant spongiotrophoblast layer. In order
to further determine whether Bruce mutants undergo
enhanced apoptosis in the embryo proper, we used an
antibody for cleaved caspase 3 on dorsal root ganglia
which express high levels of lacZ in the mutant (Fig. 2).
As shown in Figure 8G,H, there was no difference in the
number of apoptotic events in the wildtype compared
to the mutants with respect to cleaved caspase 3. There-
fore, we concluded that the primary effect of this Bruce
allele is not an elevation of apoptosis. In order to deter-
mine whether spongiotrophoblast cells proliferate nor-
mally after E10.5, we utilized an antibody specific for
phosphorylated histone H3, which is exclusively detect-
able in metaphase cells. Interestingly, as shown in Figure
9, no dividing cells were detected in the spongiotropho-
blast layer of three mutants. In contrast, between 18 and
53 proliferating cells in metaphase were found in the
spongiotrophoblast of three heterozygous littermates
(Supplemental data). From these experiments we con-
clude that Bruce is involved in the regulation of cell divi-
sion of spongiotrophoblast cells. The strong reduction
of Hif1 expression in mutant spongiotrophoblast layers
(Fig. 7) suggests that Bruce mutant spongiotrophoblast
cells do not respond to their hypoxic environment.
Taken together, our data suggest that the establishment
and patterning of the placenta is normal in the mutants.
Even in the absence of wildtype Bruce protein the spon-
giotrophoblast layer is established. Also, chorioallantoic
fusion and branching takes place with no detectable dif-
ferences between mutant and wildtype. After E10.5,
however, the cells of the spongiotrophoblast do not
appropriately respond to signals from their microenvir-
onment with further growth and expansion, which is
finally followed by death and resorption of the embryo.
DISCUSSION
As shown in this study, a mutation of the mouse Bruce/
Birc6, a gene which is widely expressed during mouse
development, has a very specific impact on the prolifera-
tion of placental spongiotrophoblast cells. Although ini-
tially established as determined by flt-1 expression, few
spongiotrophoblast cells enter metaphase after E10.5.
However, in contrast to what has been predicted from
the structure of the Bruce protein, apoptosis is not the
primary phenotype of the mouse mutants. Instead, it
appears that spongiotrophoblast cells of Bruce mutants
are unable to respond to triggering signals from their
microenvironment with proliferation. Since many cellu-
lar events that lead to a remodeling of the growing pla-
centa are triggered by oxygen, we hypothesize that
Bruce is acting downstream of hypoxia/VEGF signaling
where the Bruce protein is directly involved in cell cycle
regulation. The placental phenotype of Bruce mutants
that lead to embryonic lethality occurred with some vari-
FIG. 6. In situ hybridization of
placentas at different develop-
mental stages reveals progressive
loss of the spongiotrophoblast
layer. A,C,E:Wildtype. B,D,F:Mu-
tant. A,B: E10.5. C,D: E11.5. E,F:
E12.5. 1: Cresyl violet staining; 2:
flt-1 probe; 3: flk-1 probe; 4:
Bruce probe. d: decidua; gc: giant
cells; sp: spongiotrophoblast; lab:
labyrinth. As indicated by the
VEGF receptor flt-1, which is a
spongiotrophoblast specific mar-
ker, Bruce mutant placentas show
a relative regression of the spon-
giotrophoblast (compare C2 and
D2 as well as E2 and F2).
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ability between E11.5 and E14.5 of embryonic
development.
The variability of the phenotype could be due to influ-
ences of the genetic background with variable contribu-
tion of 129S2 and C57BL/6 in F2 intercrosses. This
hypothesis was further supported by more recent obser-
vations of homozygous mutants detected at E16.5 after
six backcrosses to C57BL/6. From a deletion mutant of
Bruce, obtained by homologous recombination, a phe-
notype similar to the gene trap mutant was obtained.
Genetic background influences have also been observed
in the knockout mutant, indicating no dominant nega-
tive effects of the truncated Bruce protein described in
this study (Lotz et al., 2004). More recently, another
gene trap mutant with an integration in intron 54 of
Bruce has been reported. Similar to our own integration,
this mutation is lethal between E11.5 and E16.5. How-
ever, in contrast to our findings and the Bruce knockout
mutant, the intron 54 integration leads to an upregula-
tion of apoptosis in both the placenta and the embryo
FIG. 7. The expression of the spongiotrophoblast markers mash2 and EGFR as well as the hypoxia-inducible factor hif1alpha are strongly
reduced in the spongiotrophoblast of the Birc6 mutant. A: In situ hybridization with a mash2 antisense probe. B: In situ hybridization with a
hif1alpha antisense probe. C: Immunohistochemistry using an EGFR antibody. The spongiotrophoblast layer of the mutants is almost nega-
tive for all three markers. A strong signal for EGFR was found around mutant giant cells but was absent from mutant spongiotrophoblast, in
contrast to the wildtype. C0: H&E staining of sections in C.
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(Ren et al., 2005). Further experiments using compound
mutants of the three different Bruce alleles may help to
dissect direct and indirect influences on the Bruce
phenotypes.
Other IAP family members have been deleted in the
mouse by homologous recombination but none exhib-
ited an apoptosis phenotype in vivo (Lens et al., 2003;
Harlin et al., 2001; Holcik et al., 2000). Similarly, knock-
out mice of the IAP inhibitor protein smac/diablo did
not exhibit any obvious phenotype, indicating high
redundancy among IAP proteins and their inhibitors
(Holcik et al., 2000). As determined for the human pla-
centa, all IAP proteins tested were expressed in this tis-
sue (Ka and Hunt, 2003) and could therefore compen-
sate for the absence of Bruce in terms of caspase inhibi-
tion. Theoretically, it is possible that the Bruce-betageo
fusion protein of W036C08 is still partially functional
with its residual Bir repeat. Considering the similar
knockout phenotype of Bruce, however, our data sug-
gest that the nonredundant function of Bruce is a role in
FIG. 8. Apoptosis is not the cause of the
spongiotrophoblast regression of Bruce
(Birc6Gt(pT1Betageo)45Flo) mutants. Tunel assay.
A: No terminal transferase added (negative
control). B: Partially DNAseI digested (posi-
tive control). C: Mutant placenta E11.5.
D: Heterozygous placenta E11.5: most
apoptotic cells can be found in the labyrinth,
both in the mutant and in the wildtype litter-
mate. No differences between mutants and
wildtype were observed. E: Cleaved cas-
pase 3 in mutant placenta E11.5. F: Cleaved
caspase 3 in heterozygous placenta of litter-
mate E11.5. At E11.5 most cleaved caspase
3-positive cells are located in the labyrinth,
both in the mutant and in the wildtype
placenta. No differences between mutant
and wildtype placenta were observed for
cleaved caspase 3. G: Cleaved caspase 3
immunohistochemistry on dorsal root gan-
glia of mutant embryos at E11.5 as a control
tissue, in which Bruce is strongly expressed
and where apoptosis is frequent, indicates
no enhanced apoptosis phenotype as com-
pared to wildtype littermates (H).
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cell cycle regulation. Bruce is the only IAP protein
known with E2 enzyme capabilities (Hauser et al.,
1998). Thus, none of the other IAP members could com-
pensate for the ubiquitin-conjugating activity of Bruce.
In the mutant protein, the UBC domain of Bruce is
replaced by betageo (Fig. 1). Ubiquitination is an impor-
tant tool of the cell to rapidly and selectively eliminate
proteins that need to be kept under tight regulation. A
well-known example is the inactivation of p53 via ubiq-
uitination through mdm2 (for a review, see Vogelstein
et al., 2000). The amount of p53 protein as well as its
state of activity is crucial to life or death decisions within
a cell. A pathway directed against mdm2 activity on p53
is p14ARF, which is capable of sequestering mdm2 in the
nucleoli and drives the cell irreversibly into senescence
(Tao and Levine, 1999). The role of p53, mdm2, and
p14ARF during placentation is yet unknown; however,
administration of the DNA-damaging agent 1-b-D-Arabi-
nofuranosylcysteine (Ara-C) to pregnant rats has led to
p53-mediated defects in the placental labyrinth. There-
fore, p53 can play a role during the differentiation of pla-
cental cells under certain conditions (Yamauchi et al.,
2004). Under normal conditions proliferation, differen-
tiation, or apoptotic events of placental cells are trig-
gered by hypoxia, as shown in vivo and in vitro (Adel-
man et al., 2000; Levy et al., 2000). More recently, it has
been demonstrated that hypoxia can lead to an accumu-
lation of unfolded proteins in the endoplasmic reticulum
(ER stress). Under normal conditions, ER stress leads to
phosphorylation and subsequent transportation of p53
into the cytoplasm, where it can be degraded by ubiqui-
tination (Stavridi and Halazzonetis, 2004; Qu et al.,
2004). According to the results of Ren et al. (2005), p53
is a direct target of Bruce and it is tempting to speculate
that p53 protein in spongiotrophoblast cells of the
Birc6Gt(pT1Betageo)45Flo mutant leads to irreversible cellu-
lar senescence rather than proliferation or apoptosis.
The answer to this question and an explanation for the
different gene trap mutant phenotypes may be
addressed by breeding the different Bruce alleles on a
p53-negative genetic background.
Based on our data, we conclude that Bruce, similar to
its evolutionary closest IAP relative Survivin, does not
have a function in cell death in vivo, at least none that
cannot be compensated for by one of the other IAP pro-
teins. However, a unique function of Bruce during
mouse development lies in the regulation of spongiotro-
phoblast cell proliferation. The cellular function of
Bruce in proliferation control needs to be further investi-
gated by biochemical and cell biological means.
Interestingly, in lower organisms like nematode and
yeast, mutations in IAP proteins had a primary impact
on cell cycle and not apoptosis. In vertebrate cells, how-
ever, all IAP proteins are capable of inhibiting apoptosis
when overexpressed in vitro, but only Survivin (Lens
et al., 2003) has been demonstrated to have retained its
direct impact on the cell cycle. In this study, we present
evidence that Bruce/Birc6 also plays a role in cell cycle
regulation and does not cause an increase of apoptotic
events in vivo when mutated. The molecular events that
lead to unresponsiveness of spongiotrophoblast cells to
triggering signals on a Bruce-negative background
FIG. 9. No detectable prolifera-
tion of / spongiotrophoblast
cells at E11.5. By utilizing an anti-
body against phosphohistone H3,
which detects only cells in meta-
phase, we detected proliferating
cells (arrows) in mutant labyrinth
(A) but not in the spongiotropho-
blasts at E11.5. However, meta-
phase cells were found in the
wildtype spongiotrophoblast and
in wildtype labyrinth (C). Note also
that the mutant spongiotropho-
blast is significantly reduced in
size as compared to the wildtype.
A,B: Mutant. C,D: Wildtype. B,D:
H&E staining. A,C: Phosphohi-
stone H3 immunohistochemistry.
gia: giant cells, spo: spongiotro-
phoblast, la: labyrinth.
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remains to be revealed. Most interestingly, the situation
of the developing placenta under low oxygen and high
IAP protein expression level is similar to tumor develop-
ment. The expression of Apollon, the human homolog
of Bruce, was found to be upregulated in four of six
brain cancer (glioma) as well as in one of five ovarian
cancer cell lines (Chen et al., 1999). The mutant allele of
Bruce presented in this study will provide a valuable
resource to understand its role during placental develop-
ment and cancer.
MATERIALS AND METHODS
Generation of ES Cells
The generation of the ES cell clone W036C08 has been
described (Hansen et al., 2003; Wiles et al., 2000). In
brief, the plasmid vector pT1betageo was HindIII linear-
ized and electroporated into tbv-2 ES cells (129S2).
G418 selection was applied at 200 ng/ml for 8 days.
Mutant ES cell clones were identified by 50 RACE and
direct sequencing of PCR products (Wiles MV et al.,
2000).
Production and Breeding of Mouse Line
ES cells were injected as described (Hansen et al., 2003)
and male chimeras were bred with C57BL/6 females.
The resulting mouse line W036C08 was bred on a
C57BL/6 background for six generations. The initial anal-
ysis was done using F2 animals.
Genomic DNA Isolation and Southern Blotting
Genomic DNA was isolated from mouse tails or ES cells
using the Wizard genomic DNA system from Promega
(Madison, WI). DNA was digested overnight, heated to
608C in loading buffer and run on 0.8% agarose gels at
30V for 12 h. Gels were blotted on Hybond N plus mem-
branes (Amersham, Arlington Heights, IL) according to
standard procedures (Ausubel et al., 1989). An 800-bp
PstI fragment was isolated from a PGK-neo plasmid
(Adra et al., 1987; gift of T. Braun) and used as an inter-
nal probe. In order to distinguish between single and
multiple vector integration, genomic DNA from the
W036C08 ES clone was digested with HindIII, which
does not cut in pT1betageo, and with EcoRI, which cuts
once in pT1betageo (Wiles et al., 2000; Fig. 1). As a load-
ing control we used an 850-bp SalI/EcoRI genomic probe
for engrailed-1 (ESN; a gift of J. Guimera), which will
yield a 6.2-kb fragment after EcoRI digestion and a 8.9
kb fragment after HindIII digestion.
PCR Primers and Conditions
PCR was performed with 1.25U Taq polymerase from
Fermentas and 20–50 ng DNA or cDNA in 50 ll total
according to standard conditions after initial melting at
948C for 60 s and with final extension at 728C for 7 min
on an Eppendorf Master Cycler Thermocycler Gradient.
Mouse flk1 cDNA probe: ‘‘flk1–3199’’: 50-TCTTTCGGT-
GTGTTGCTCTG-30, ‘‘flk1–3574’’: 50-CATAATGGAATT-
TGGGGTCG-30; 958C for 20 s, 518C for 20 s, 728C for
70 s, repeat 35 cycles, product size: 376 bp.
Mouse flt1 cDNA probe: ‘‘flt1-424’’: 50-CTTTCTCAA-
GTGCAGAGGGG-30, ‘‘flt1–725’’: 50-TCATGTGCACAA-
GTTTGGGT-3; 958C for 20 s;, 518C for 20 s, 728C for
70 s, repeat 35 cycles, product size: 302 bp.
Determination of integration site of clone W036C08:
‘‘Intrev_1489’’: 50-GCAAGAGTGTCCGTGACCAC-30, ‘‘lac2’’:
50-CAAGGCGATTAAGTTGGGTAACG-30; 958C for 60 s,
518C for 40 s, 728C for 60 s, repeat 35 cycles, product
size: 830bp.
Routine genotyping of W036C08: ‘‘722F’’: 50-TGCAGG-
AATGGGGTACATTT-30, ‘‘505 Race’’: 50-GCCGCTTGTCCT-
CTTTGTTAGG-30, ‘‘1489’’: 50-GCAAGAGTGTCCGTGACC-
AC-30; 948C for 60 s, 56.58C for 40 s, 728C for 60 s,
repeat 35 cycles, product sizes: 767 bp (wt), 820 bp
(mut).
All PCR products were subcloned initially in TOPO TA
(Invitrogen, La Jolla, CA) and sequence-verified. 50RACE
was performed as described previously (Hansen et al.,
2003).
Western Analysis
Western blotting was performed using the following
antibodies: Anti-b-galactosidase, mouse monoclonal
(Roche, Nutley, NJ); 1:4,000. Anti-b-actin, goat polyclo-
nal (Santa Cruz Biologicals, Santa Cruz, CA); 1:1,000.
Anti-Bruce N-terminal, mouse monoclonal; (Transduc-
tion Laboratories, Lexington, KY); 1:1,000. Anti-Bruce C-
terminal, rabbit polyclonal (Hauser, AG Jentsch) 1:100.
Antimouse, polyclonal, goat peroxidase coupled (Dia-
nova), 1:10,000. Antirabbit, polyclonal, goat peroxidase
coupled (Dianova), 1:10,000. Antigoat, polyclonal,
donkey peroxidase coupled (Sigma, St. Louis, MO),
1:10,000.
E10.5 embryos or tissues were homogenized in 150 ll
of PBS (phosphate-buffered saline) containing protease
inhibitor (complete, Roche) using a micropipette, subse-
quently, 45 ll of 5 Laemmli buffer (Laemmli, 1970)
were added, mixed, and incubated at 948C for 10 min.
Then 12.5 ll of the lysate per lane were either loaded
directly on SDS gels or stored at 808C until use.
Gradient acrylamide gels of 4–20% were run in Mighty
Small Gelsystems (Hoeffer Scientific, San Francisco, CA)
in 1 SDS buffer at 20–40 mA for 2–3 h. Bench Mark Pre-
stained Protein Ladder (Invitrogen) was used as a molec-
ular standard.
Proteins were transferred to a PVDF membrane (Milli-
pore, Bedford, MA) using a tankblot system at 70V at 48C
overnight (Burnette, 1981). Immunochemistry was per-
formed using specific antibodies in blocking solution
(4% slim milk) for 1 h at room temperature (RT), after
5 washing in TBST and incubation with a peroxidase-
coupled secondary antibody for 45 min at RT and subse-
quent 5 washing in TBST, immunoreaction via chemi-
luminescence was carried out using ECL Western Blot-
ting Detection reagents (Amersham) according to the
manufacturer’s recommendations.
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In Situ Hybridization
In order to generate a Bruce antisense probe, the plas-
mid pBR-M1 (a gift of S. Jentsch, Munich) was XhoI
digested and transcribed with T7 RNA polymerase. For
the sense control, the same plasmid was digested with
SacI and transcribed with T3 RNA polymerase. The RT-
PCR products from wildtype placenta for flt-1 and flk-1
were cloned in TOPO TA (Invitrogen) and recloned as
EcoRI fragments in pBluescript II KSþ (Stratagene, La
Jolla, CA). The plasmid flt1 was digested BamHI and tran-
scribed T3 for antisense or HindIII/T7 for sense tran-
script. As for the plasmid flk1: HindIII/T7 (antisense) or
PstI/T3 (sense). A mash 2 probe was amplified from pla-
cental cDNA using the primers CTCTGTCCTGCG-
CCTCTACGTC and AGTCACCCAGGGATGCAGCTTA.
The probe was cloned in pCRII-TOPO and sequenced.
The plasmid mash2 was digested with HindIII and tran-
scribed T7 for antisense or BamHI/T3 for sense tran-
script. A Hif1alpha probe was amplified from placental
cDNA using the primers CGACACCATCATCTCTCTGG
and AGTGGCAGTGATGGTAGG. The probe was cloned
in pCRII-TOPO and sequenced. The plasmid Hif1al-
phaA1 was digested XhoI and transcribed T3 for anti-
sense or digested BamHI/T7 for sense transcript. In situ
hybridizations were performed as described previously
(Dagerlind et al., 1992).
b-Gal Staining of Embryos
b-Gal staining of embryos was performed between E8.5
and E12.5 as described previously (Floss and Wurst,
2002).
Paraffin Sections
For immunohistochemistry and in situ hybridization, tis-
sues were fixed in 4% PFA solution at 48C for 60 min and
incubated in 70% EtOH at 48C for 60 min; 96% EtOH at
RT for 45 min; 96% EtOH at RT for 30 min; 100% EtOH
at RT for 45 min; 100% EtOH at RT for 30 min; Xylol at
RT for 30 min; Xylol at RT for 30 min; paraffin at 658C
for 120 min. The tissue was sectioned at 4–8 lm on a
microtome, air-dried at 378C overnight, and stored at
48C or used directly.
Immunhistochemistry
Immunhistochemistry was performed on paraffin sec-
tions using antibodies against phospho-Histone H3 (Lot
26414; Upstate Biotechnology, Lake Placid, NY), EGFR
(sc-03; Santa Cruz) and Cleaved Caspase 3 (Asp175; Cell
Signaling Technology, Beverly, MA) according to the
manufacturer’s protocols.
Tunel Assays
Tunel assays were performed on 8 lm paraffin sections
after deparaffination with xylene and decreasing alcohol
solutions (100%, 95%, and 70%, water) and permeabiliza-
tion for 3 min in 0.3M sodium citrate at RT and 4 min
heating in a microwave at 600W. After cooling to RT, sec-
tions were washed 2 with PBS.
Assays were performed using a Tunel kit (Lot D16560;
UniTect) according to the manufacturer’s protocols. His-
tochemistry was done with cresyl violet or hematoxylin-
eosin by standard protocols (Bancroft and Stevens,
1990).
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